Prasad Neerati

798 total citations
36 papers, 632 citations indexed

About

Prasad Neerati is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Prasad Neerati has authored 36 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 16 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Prasad Neerati's work include Drug Transport and Resistance Mechanisms (15 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Prasad Neerati is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Prasad Neerati collaborates with scholars based in India, Australia and Malaysia. Prasad Neerati's co-authors include Kislay Roy, Jagat R. Kanwar, Narsimha Reddy Yellu, Ganesh Mahidhara, Sreenivasan Sasidharan, Rakesh Sehgal, Subramanian Krishnakumar, Vasanthanathan Poongavanam, Janez Plavec and Maja Marušič and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and Scientific Reports.

In The Last Decade

Prasad Neerati

35 papers receiving 614 citations

Peers

Prasad Neerati

PHARM

ONCOL

PHARM

Guru R. Valicherla India

Emmanuel Omari‐Siaw China

BC Koti India

Firoz Anwar India

Bassant M. M. Ibrahim Egypt

Silvester Poništ Slovakia

Agadi Hiremath Viswanatha Swamy India

Aracely Evangelina Chávez‐Piña Mexico

Heba M. I. Abdallah Egypt

Guru R. Valicherla India

Prasad Neerati

220 ×1.1

76 ×0.5

PHARM

83 ×0.8

ONCOL

55 ×0.6

PHARM

35 ×0.5

Citations per year, relative to Prasad Neerati Prasad Neerati (= 1×) peers Guru R. Valicherla

Countries citing papers authored by Prasad Neerati

Since Specialization

Citations

This map shows the geographic impact of Prasad Neerati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasad Neerati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasad Neerati more than expected).

Fields of papers citing papers by Prasad Neerati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prasad Neerati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasad Neerati. The network helps show where Prasad Neerati may publish in the future.

Co-authorship network of co-authors of Prasad Neerati

This figure shows the co-authorship network connecting the top 25 collaborators of Prasad Neerati. A scholar is included among the top collaborators of Prasad Neerati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prasad Neerati. Prasad Neerati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Neerati, Prasad, et al.. (2025). Enhancing the anti-cancer potential of resveratrol through cocrystal technology in colorectal cancerous rats. Scientific Reports. 15(1). 44606–44606.

Neerati, Prasad, et al.. (2021). Novel Indole Derivative as the First P-glycoprotein Inhibitor from the Skin of Indian Toad <i>(Bufo melanostictus)</i>. Turkish Journal of Pharmaceutical Sciences. 19(1). 63–69. 1 indexed citations

Neerati, Prasad, et al.. (2021). Alpha lipoic acid attenuated neuropathic pain induced by chronic constriction Injury of sciatic nerve in rats. SHILAP Revista de lepidopterología. 7(1). 2 indexed citations

Neerati, Prasad, et al.. (2020). Enhanced oral bioavailability of diltiazem by resveratrol in healthy human subjects: An open-label, two-period, sequential study. Journal of Natural Science Biology and Medicine. 11(2). 100. 2 indexed citations

Neerati, Prasad, et al.. (2020). Evidence-based P-glycoprotein inhibition by green tea extract enhanced the oral bioavailability of atorvastatin: from animal and human experimental studies. Journal of Natural Science Biology and Medicine. 11(2). 105. 2 indexed citations

Neerati, Prasad, et al.. (2018). Improved neuroprotective effect of resveratrol nanoparticles as evinced by abrogation of rotenone-induced behavioral deficits and oxidative and mitochondrial dysfunctions in rat model of Parkinson’s disease. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(4). 445–453. 66 indexed citations

Neerati, Prasad, et al.. (2017). The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects. European Journal of Clinical Pharmacology. 74(1). 91–97. 21 indexed citations

Neerati, Prasad, et al.. (2017). Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats. Xenobiotica. 48(10). 1028–1036. 6 indexed citations

Neerati, Prasad, et al.. (2017). Enhanced Oral Bioavailability of Domperidone with Piperine in Male Wistar Rats: Involvement of CYP3A1 and P-gp Inhibition. Journal of Pharmacy & Pharmaceutical Sciences. 20. 28–28. 33 indexed citations

10.

Neerati, Prasad, et al.. (2017). Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(2). 115–121. 12 indexed citations

11.

Roy, Kislay, Prasad Neerati, Chun Hei Antonio Cheung, Jagat R. Kanwar, & Rajat Sandhir. (2017). Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze. Frontiers in Pharmacology. 8. 1434–1434. 4 indexed citations

12.

Neerati, Prasad, et al.. (2016). Enhanced oral bioavailability of metoprolol with gallic acid and ellagic acid in male Wistar rats: involvement of CYP2D6 inhibition. Drug Metabolism and Personalized Therapy. 31(4). 229–234. 26 indexed citations

13.

Neerati, Prasad, et al.. (2016). Effects of ritonavir on the pharmacokinetics and pharmacodynamics of pioglitazone in normal and diabetic rats. Journal of Pharmacy Research. 958–962. 1 indexed citations

14.

Neerati, Prasad, et al.. (2016). Enhancement of oral bioavailability of rivastigmine with quercetin nanoparticles by inhibiting CYP3A4 and esterases. Pharmacological Reports. 69(2). 365–370. 21 indexed citations

15.

Neerati, Prasad. (2015). Detection of antidiabetic activity by crude paratoid gland secretions from common Indian toad (bufomelano stictus). Journal of Natural Science Biology and Medicine. 6(2). 429–429. 2 indexed citations

16.

Yellu, Narsimha Reddy, et al.. (2015). Effect of resveratrol on the pharmacokinetics of fexofenadine in rats: Involvement of P-glycoprotein inhibition. Pharmacological Reports. 68(2). 338–343. 16 indexed citations

17.

Neerati, Prasad, et al.. (2014). Effect of diosmin on the intestinal absorption and pharmacokinetics of fexofenadine in rats. Pharmacological Reports. 67(2). 339–344. 25 indexed citations

18.

Neerati, Prasad, et al.. (2011). Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats. European Journal of Pharmaceutical Sciences. 44(1-2). 27–31. 29 indexed citations

19.

Neerati, Prasad, et al.. (2010). Influence of atorvastatin on the pharmacokinetics and pharmacodynamics of glyburide in normal and diabetic rats. European Journal of Pharmaceutical Sciences. 42(3). 285–289. 13 indexed citations

20.

Neerati, Prasad, et al.. (2009). Dipeptidyl peptidase-IV (DPP-IV) inhibitory activity of parotid exudate of Bufo melanostictus. Pharmacognosy Research. 1(2). 98. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact